DARVOCET Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Darvocet, and what generic alternatives are available?
Darvocet is a drug marketed by Aaipharma Llc and Xanodyne Pharm and is included in three NDAs.
The generic ingredient in DARVOCET is acetaminophen; propoxyphene napsylate. There are sixty-six drug master file entries for this compound. Additional details are available on the acetaminophen; propoxyphene napsylate profile page.
Summary for DARVOCET
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 172 |
| Clinical Trials: | 1 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | DARVOCET at DailyMed |
Recent Clinical Trials for DARVOCET
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Rochester | Phase 4 |
| Endo Pharmaceuticals | Phase 4 |
US Patents and Regulatory Information for DARVOCET
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aaipharma Llc | DARVOCET | acetaminophen; propoxyphene hydrochloride | TABLET;ORAL | 016844-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Xanodyne Pharm | DARVOCET-N 50 | acetaminophen; propoxyphene napsylate | TABLET;ORAL | 017122-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Xanodyne Pharm | DARVOCET A500 | acetaminophen; propoxyphene napsylate | TABLET;ORAL | 076429-001 | Sep 10, 2003 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Xanodyne Pharm | DARVOCET-N 100 | acetaminophen; propoxyphene napsylate | TABLET;ORAL | 017122-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
